ATTENTION RESEARCHERS: JOIN US AT OUR SLC13A5 INTERNATIONAL RESEARCH ROUNDTABLE! REGISTER HERE.

ABOUT
TESS
- Team
- Financials
- Newsletter
- Press Kit
- Blog
- Our Partners
- Impact Report
UNDERSTANDING
SLC13A5
PATIENTS
& CAREGIVERS
PHYSICIANS
& RESEARCHERS
GET
INVOLVED
DONATE NOW
Language

Afrikaans Albanian Amharic Arabic Basque Bengali Bosnian Bulgarian Catalan Cebuano Corsican Danish Dutch English Estonian Filipino French Frisian Galician Georgian German Hawaiian Italian Japanese Javanese Kannada Lao Latin Latvian Malagasy Russian Spanish Swahili Swedish Tamil Telugu Thai Turkish Ukrainian Urdu Uzbek Yoruba Zulu

ABOUT
TESS
- Team
- Financials
- Newsletter
- Press Kit
- Blog
- Our Partners
- Impact Report
UNDERSTANDING
SLC13A5
PATIENTS
& CAREGIVERS
PHYSICIANS
& RESEARCHERS
GET
INVOLVED
DONATE NOW
Language

Afrikaans Albanian Amharic Arabic Basque Bengali Bosnian Bulgarian Catalan Cebuano Corsican Danish Dutch English Estonian Filipino French Frisian Galician Georgian German Hawaiian Italian Japanese Javanese Kannada Lao Latin Latvian Malagasy Russian Spanish Swahili Swedish Tamil Telugu Thai Turkish Ukrainian Urdu Uzbek Yoruba Zulu

Newsletter

01 Oct Reminder: SLC13A5 Webinar Event This...

October 1, 2019

TESS Research Foundation Newsletter Read this Issue...

Read More

TESS Research Family Updates Sept 2019

TESS Research Family Updates Sept 2019

09 Sep TESS Research Family Updates Sept 2019

September 9, 2019

TESS Research Foundation Newsletter Read this Issue...

Read More

Meet our current TESS Grant Recipients!

Meet our current TESS Grant Recipients!

28 Jun Meet our current TESS Grant Recipients!

June 28, 2019

TESS Research Foundation Newsletter Read this Issue...

Read More

There’s Still Time to Double Your Impact: The New Horizon for Research at TESS, Gene Therapy, & Matching Donations

There’s Still Time to Double Your Impact: The New Horizon for Research at TESS, Gene Therapy, & Matching Donations

30 Dec There’s Still Time to Double Your...

December 30, 2018

TESS Research Foundation Newsletter Read this Issue...

Read More

⏰ Research Proposals Due December 1 ⏰

⏰ Research Proposals Due December 1 ⏰

26 Nov ⏰ Research Proposals Due December...

November 26, 2018

TESS Research Foundation Newsletter Read this Issue...

Read More

Read all about our Research Funding Opportunity, Conference and More!

Read all about our Research Funding Opportunity, Conference and More!

06 Nov Read all about our Research Funding...

November 6, 2018

Read this Issue...

Read More

Last Chance for Pau Gasol #OneDayOneDream Sweepstakes & TESS in the News

Last Chance for Pau Gasol #OneDayOneDream Sweepstakes & TESS in the News

15 Mar Last Chance for Pau Gasol #OneDayOneDream...

March 15, 2018

TESS Research Foundation Newsletter Read this Issue...

Read More

Partnership with NBA player Pau Gasol for #OneDayOneDream Sweepstakes

Partnership with NBA player Pau Gasol for #OneDayOneDream Sweepstakes

09 Mar Partnership with NBA player Pau Gasol...

March 9, 2018

TESS Research Foundation Newsletter Read this Issue...

Read More

World Rare Disease Day, News Coverage, & Partnership with Pau Gasol

World Rare Disease Day, News Coverage, & Partnership with Pau Gasol

28 Feb World Rare Disease Day, News Coverage,...

February 28, 2018

TESS Research Foundation Newsletter Read this Issue...

Read More

1
2
3
4

Search for:

Categories

Families (8)
General (5)
News (22)
Newsletter (28)
Press Release (1)
Research (3)
Science Simplified (14)
Superheroes (25)
TESS Team (2)

STAY INFORMED

Subscribe to our e-newsletter to receive updates on the latest SLC13A5 research, treatment and news and join the TESS community.

Make a Donation

We can’t do it without you. Your support goes to funding critical SLC13A5 Epilepsy research.
DONATE TODAY!

TESS Research Foundation
655 Oak Grove Ave #53
Menlo Park, CA 94026
(650)521-2279
info@tessfoundation.org
A 501(c)(3) nonprofit corporation.
Tax ID: 47-3108868

Follow TESS

©2022 TESS Research Foundation | The information you obtain at this site is not, nor is it intended to be, medical advice. Full Dislaimer.

Privacy Statement
Terms of Use